Breckenridge Announces Final Approval of its ANDA for Imatinib Mesylate Tablets (RLD: Gleevec(r))

Source :: Plus Company Updates. March 5, 2019
Publication Year :: 2019
Abstract: BOCA RATON: Breckenridge Pharmaceutical, Inc. has issued the following press release: Breckenridge Pharmaceutical, Inc. announced that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New [...]

Subjects :: Novartis AG -- Planning
Pharmaceutical industry -- Planning
Drug approval
Imatinib mesylate -- Planning
Antineoplastic agents
Generic drugs
Company business planning
General interest
News, opinion and commentary
Gleevec (Medication)

Tools